{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:58:48Z","timestamp":1780412328853,"version":"3.54.1"},"reference-count":91,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To investigate the effects of Alogliptin in chemical-induced post-menopausal osteoporosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methodology<\/jats:title>\n                  <jats:p>The binding affinity of alogliptin with osteogenic proteins was analysed in silico. The effect of alogliptin on osteogenic proteins and mineralization of osteoblastic cells was evaluated in UMR-106 cells. Further, in vivo anti-osteoporotic activity of alogliptin was evaluated in postmenopausal osteoporosis. Various bone turnover markers were assayed in serum. This followed the analysis of microarchitecture of bone, histology, and immunohistochemistry (IHC) of bone tissue.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Docking scores showed that alogliptin has binding affinity for bone alkaline phosphatase (BALP), osteocalcin, and bone morphogenic protein (BMP-2). Alogliptin also enhanced mineralization of osteoblast cells, evidenced with increased ALP, osteocalcin, and BMP-2. Animal studies revealed significant elevation of bone formation markers, bone ALP, osteocalcin and BMP-2, and decreased bone resorption markers, receptor activator of NF-\u03ba\u03b2 (RANKL), cathepsin K (CTSK), tartrate resistant acid phosphatase (TRAcP5b) in VCD-induced post-menopausal osteoporosis. Micro computed tomography (\u03bcCT) analysis and histology of femur bone and lumbar vertebrae demonstrated decrease in trabecular separation and improved bone density. IHC of femur showed reduced DPP4 enzyme.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Alogliptin increased mineralization in osteoblast cells. It had beneficial effects also altered bone turnover markers, repaired the trabecular microstructure, improved bone mineral density, and exhibited bone forming capacity targeting DPP-4 enzyme in postmenopausal osteoporosis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jpp\/rgae112","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T14:18:48Z","timestamp":1727965128000},"page":"668-684","source":"Crossref","is-referenced-by-count":4,"title":["Osteogenic effect of alogliptin in chemical-induced bone loss: a tri-modal <i>in silico<\/i>, <i>in vitro,<\/i> and <i>in vivo<\/i> analysis"],"prefix":"10.1093","volume":"77","author":[{"given":"Faraha","family":"Ahmed","sequence":"first","affiliation":[{"name":"Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard , New Delhi 110062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Sufian","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard , New Delhi 110062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mumtaz","family":"Alam","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard , New Delhi 110062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Shaquiquzzaman","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard , New Delhi 110062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Altamish","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard , New Delhi 110062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuja","family":"Krishnan","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, School of Interdisciplinary Science and Technology, Jamia Hamdard , New Delhi 110062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Vohora","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard , New Delhi 110062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9299-414X","authenticated-orcid":false,"given":"Abul Kalam","family":"Najmi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard , New Delhi 110062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7401-3299","authenticated-orcid":false,"given":"Mohammad Ahmed","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard , New Delhi 110062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,3]]},"reference":[{"key":"2025050201523188500_CIT0001","doi-asserted-by":"publisher","first-page":"5727","DOI":"10.18632\/aging.204172","article-title":"The therapeutic effect of Fufang Zhenshu Tiaozhi (FTZ) on osteoclastogenesis and ovariectomized-induced bone loss: evidence from network pharmacology, molecular docking and experimental validation","volume":"14","author":"Chen","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"2025050201523188500_CIT0002","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cdtm.2015.02.006","article-title":"Primary osteoporosis in postmenopausal women","volume":"1","author":"Ji","year":"2015","journal-title":"Chronic Dis Transl Med"},{"key":"2025050201523188500_CIT0003","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bone.2017.08.008","article-title":"Glucose metabolism in bone","volume":"115","author":"Karner","year":"2018","journal-title":"Bone"},{"key":"2025050201523188500_CIT0004","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S11657-022-01061-5","article-title":"UK clinical guideline for the prevention and treatment of osteoporosis","volume":"17","author":"Gregson","year":"2022","journal-title":"Arch Osteoporos"},{"key":"2025050201523188500_CIT0005","doi-asserted-by":"publisher","first-page":"96","DOI":"10.5414\/CN110394","article-title":"The relationship between glycemic control and osteocalcin, type 1 collagen C-terminal telopeptide, bone-specific alkaline phosphatase and the effects of anti-diabetic regimens on circulating markers of bone turnover in newly diagnosed diabetic patients: B","volume":"96","author":"Karadeniz","year":"2021","journal-title":"Clin Nephrol"},{"key":"2025050201523188500_CIT0006","doi-asserted-by":"publisher","first-page":"100135","DOI":"10.1016\/j.hsr.2023.100135","article-title":"Hyperglycaemia induced osteoporosis: Is there a hope with dipeptidyl peptidase-4 inhibitors","volume":"9","author":"Ahmed","year":"2023","journal-title":"Heal Sci Rev"},{"key":"2025050201523188500_CIT0007","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/FENDO.2020.00122","article-title":"The interplay between bone and glucose metabolism","volume":"11","author":"Cipriani","year":"2020","journal-title":"Front. Endocrinol (Lausanne)"},{"key":"2025050201523188500_CIT0008","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.dsx.2021.04.017","article-title":"Type 2 diabetes and bone fragility\u2014an under-recognized association","volume":"15","author":"Farooqui","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"2025050201523188500_CIT0009","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/jcp.22291","article-title":"Adipocytes decrease Runx2 expression in osteoblastic cells: Roles of PPAR\u03b3 and adiponectin","volume":"225","author":"Liu","year":"2010","journal-title":"J Cell Physiol"},{"key":"2025050201523188500_CIT0010","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1210\/jc.2012-3634","article-title":"Marrow fat and bone-new perspectives","volume":"98","author":"Fazeli","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2025050201523188500_CIT0011","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2174\/1574888x10666150531173309","article-title":"Molecular mechanisms of PPAR-\u03b3 governing MSC osteogenic and adipogenic differentiation","volume":"11","author":"Zhuang","year":"2016","journal-title":"Curr Stem Cell Res Ther"},{"key":"2025050201523188500_CIT0012","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1002\/stem.1659","article-title":"Switch from canonical to noncanonical Wnt signaling mediates high glucose-induced adipogenesis","volume":"32","author":"Keats","year":"2014","journal-title":"Stem Cells"},{"key":"2025050201523188500_CIT0013","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s00223-016-0210-y","article-title":"Bone-derived factors: a new gateway to regulate glycemia","volume":"100","author":"Bonnet","year":"2017","journal-title":"Calcif Tissue Int"},{"key":"2025050201523188500_CIT0014","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1172\/JCI125915","article-title":"RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass","volume":"129","author":"Bonnet","year":"2019","journal-title":"J Clin Invest"},{"key":"2025050201523188500_CIT0015","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.2040-1124.2010.00022.x","article-title":"GIP and GLP-1, the two incretin hormones: similarities and differences","volume":"1","author":"Seino","year":"2010","journal-title":"J. Diabetes Investig"},{"key":"2025050201523188500_CIT0016","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/DOM.13129","article-title":"Incretin hormones: their role in health and disease","volume":"20","author":"Nauck","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"2025050201523188500_CIT0017","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1359\/jbmr.2003.18.12.2180","article-title":"Role of gastrointestinal hormones in postprandial reduction of bone resorption","volume":"18","author":"Henriksen","year":"2003","journal-title":"J Bone Miner Res"},{"key":"2025050201523188500_CIT0018","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1210\/endo.141.3.7366","article-title":"Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors","volume":"141","author":"Bollag","year":"2000","journal-title":"Endocrinology"},{"key":"2025050201523188500_CIT0019","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1472-6793-11-12","article-title":"Receptors and effects of gut hormones in three osteoblastic cell lines","volume":"11","author":"Pacheco-Pantoja","year":"2011","journal-title":"BMC Physiol"},{"key":"2025050201523188500_CIT0020","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/iub.1709","article-title":"Significance of circulatory DPP4 activity in metabolic diseases","volume":"70","author":"Nargis","year":"2018","journal-title":"IUBMB Life"},{"key":"2025050201523188500_CIT0021","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1002\/jbmr.2277","article-title":"Blockade of CD26 signaling inhibits human osteoclast development","volume":"29","author":"Nishida","year":"2014","journal-title":"J Bone Miner Res"},{"key":"2025050201523188500_CIT0022","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1359\/JBMR.051004","article-title":"Immunocompetent properties of human osteoblasts: interactions with T lymphocytes","volume":"21","author":"Stanley","year":"2006","journal-title":"J Bone Miner Res"},{"key":"2025050201523188500_CIT0023","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1093\/CLINCHEM\/34.12.2499","article-title":"Activity of dipeptidyl peptidase IV and post-proline cleaving enzyme in sera from osteoporotic patients","volume":"34","author":"Gotoh","year":"1988","journal-title":"Clin Chem"},{"key":"2025050201523188500_CIT0024","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00198-016-3839-5","article-title":"Association of circulating dipeptidyl-peptidase 4 levels with osteoporotic fracture in postmenopausal women","volume":"28","author":"Kim","year":"2017","journal-title":"Osteoporos Int"},{"key":"2025050201523188500_CIT0025","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.metabol.2013.09.010","article-title":"Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells","volume":"63","author":"Lee","year":"2014","journal-title":"Metabolism"},{"key":"2025050201523188500_CIT0026","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3389\/fendo.2019.00389","article-title":"Clinical use of DPP-4 inhibitors","volume":"10","author":"Gallwitz","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025050201523188500_CIT0027","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/FENDO.2022.856954","article-title":"The multiple biological functions of dipeptidyl peptidase-4 in bone metabolism","volume":"13","author":"Yang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025050201523188500_CIT0028","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fendo.2019.00075","article-title":"Gut hormones and their effect on bone metabolism. potential drug therapies in future osteoporosis treatment","volume":"10","author":"Schiellerup","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025050201523188500_CIT0029","doi-asserted-by":"publisher","first-page":"101574","DOI":"10.1016\/j.xcrm.2024.101574","article-title":"Therapeutic avenues in bone repair: Harnessing an anabolic osteopeptide, PEPITEM, to boost bone growth and prevent bone loss","volume":"5","author":"Lewis","year":"2024","journal-title":"Cell Rep Med"},{"key":"2025050201523188500_CIT0030","doi-asserted-by":"publisher","first-page":"e0187537","DOI":"10.1371\/journal.pone.0187537","article-title":"The effects of dipeptidyl peptidase-4 inhibitors on bone fracture among patients with type 2 diabetes mellitus: a network meta-analysis of randomized controlled trials","volume":"12","author":"Yang","year":"2017","journal-title":"PLoS One"},{"key":"2025050201523188500_CIT0031","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J Med Chem"},{"key":"2025050201523188500_CIT0032","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1080\/21655979.2021.1900633","article-title":"Trelagliptin stimulates osteoblastic differentiation by increasing runt-related transcription factor 2 (RUNX2): a therapeutic implication in osteoporosis","volume":"12","author":"Shao","year":"2021","journal-title":"Bioengineered"},{"key":"2025050201523188500_CIT0033","doi-asserted-by":"publisher","first-page":"118543","DOI":"10.1016\/j.lfs.2020.118543","article-title":"Systemic changes in a mouse model of VCD-induced premature ovarian failure","volume":"262","author":"Cao","year":"2020","journal-title":"Life Sci"},{"key":"2025050201523188500_CIT0034","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1359\/jbmr.080309","article-title":"Comparison of skeletal effects of ovariectomy versus chemically induced ovarian failure in mice","volume":"23","author":"Wright","year":"2008","journal-title":"J Bone Miner Res"},{"key":"2025050201523188500_CIT0035","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3109\/19396368.2011.648820","article-title":"4-vinylcyclohexene diepoxide: a model chemical for ovotoxicity","volume":"58","author":"Kappeler","year":"2012","journal-title":"Syst Biol Reprod Med"},{"key":"2025050201523188500_CIT0036","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/s0890-6238(98)00061-6","article-title":"Early effects of ovotoxicity induced by 4-vinylcyclohexene diepoxide in rats and mice","volume":"13","author":"Kao","year":"1999","journal-title":"Reprod Toxicol"},{"key":"2025050201523188500_CIT0037","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/157340911795677602","article-title":"Molecular docking: a powerful approach for structure-based drug discovery","volume":"7","author":"Meng","year":"2011","journal-title":"Curr Comput Aided Drug Des"},{"key":"2025050201523188500_CIT0038","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF02557679","article-title":"Characterization on an osteoblast-like clonal cell line which responds to both parathyroid hormone and calcitonin","volume":"37","author":"Forrest","year":"1985","journal-title":"Calcif Tissue Int"},{"key":"2025050201523188500_CIT0039","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1177\/1060028013504076","article-title":"Alogliptin: a new dipeptidyl peptidase-4 inhibitor for type 2 diabetes mellitus","volume":"47","author":"Jarvis","year":"2013","journal-title":"Ann Pharmacother"},{"key":"2025050201523188500_CIT0040","doi-asserted-by":"publisher","first-page":"112313","DOI":"10.1016\/j.ejmech.2020.112313","article-title":"Synthesis and biological activities of drugs for the treatment of osteoporosis","volume":"197","author":"Zhou","year":"2020","journal-title":"Eur J Med Chem"},{"key":"2025050201523188500_CIT0041","doi-asserted-by":"publisher","first-page":"127138","DOI":"10.1016\/j.bmcl.2020.127138","article-title":"Induced osteoblast differentiation by amide derivatives of stilbene: the possible osteogenic agents","volume":"30","author":"Imran Ahamad","year":"2020","journal-title":"Bioorganic Med Chem Lett"},{"key":"2025050201523188500_CIT0042","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1177\/000456320003700402","article-title":"Measurement of osteocalcin","volume":"37 ( Pt 4)","author":"Lee","year":"2000","journal-title":"Ann Clin Biochem"},{"key":"2025050201523188500_CIT0043","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/ajmg.1320450205","article-title":"Formation of mineralized nodules by bone derived cells in vitro: a model of bone formation","volume":"45","author":"Beresford","year":"1993","journal-title":"Am J Med Genet"},{"key":"2025050201523188500_CIT0044","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jcjd.2018.01.006","article-title":"Dipeptidyl peptidase-4 inhibitor, vildagliptin, improves trabecular bone mineral density and microstructure in obese, insulin-resistant, pre-diabetic rats","volume":"42","author":"Charoenphandhu","year":"2018","journal-title":"Can J Diabetes"},{"key":"2025050201523188500_CIT0045","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/J.ARCHORALBIO.2019.04.018","article-title":"Sitagliptin\u2019s effects on bone tissue and osseointegration in diabetic rats","volume":"102","author":"Bautista","year":"2019","journal-title":"Arch Oral Biol"},{"key":"2025050201523188500_CIT0046","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1210\/er.2007-0014","article-title":"Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease","volume":"29","author":"Kearns","year":"2008","journal-title":"Endocr Rev"},{"key":"2025050201523188500_CIT0047","doi-asserted-by":"publisher","first-page":"105967","DOI":"10.1016\/j.phrs.2021.105967","article-title":"Urolithin A suppresses RANKL-induced osteoclastogenesis and postmenopausal osteoporosis by, suppresses inflammation and downstream NF-\u03baB activated pyroptosis pathways","volume":"174","author":"Tao","year":"2021","journal-title":"Pharmacol Res"},{"key":"2025050201523188500_CIT0048","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1016\/j.bbagen.2014.03.017","article-title":"Cysteine cathepsins and extracellular matrix degradation","volume":"1840","author":"Fonovi\u0107","year":"2014","journal-title":"Biochi. Biophys. Acta (BBA)-General"},{"key":"2025050201523188500_CIT0049","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2265.2008.03187.x","article-title":"Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction","volume":"69","author":"Yamada","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025050201523188500_CIT0050","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.cjco.2020.12.005","article-title":"Serum TRACP5b, a marker of bone resorption, is associated with adverse cardiac prognosis in hospitalized patients with heart failure","volume":"3","author":"Abe","year":"2020","journal-title":"CJC Open"},{"key":"2025050201523188500_CIT0051","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/6869452","article-title":"Psoralen and isopsoralen ameliorate sex hormone deficiency-induced osteoporosis in female and male mice","volume":"2016","author":"Yuan","year":"2016","journal-title":"Biomed Res Int"},{"key":"2025050201523188500_CIT0052","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/9050754","article-title":"Evaluation of decalcification techniques for rat femurs using HE and immunohistochemical staining","volume":"2017","author":"Liu","year":"2017","journal-title":"Biomed Res Int"},{"key":"2025050201523188500_CIT0053","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/0300985813505879","article-title":"When tissue antigens and antibodies get along","volume":"51","author":"Ramos-Vara","year":"2014","journal-title":"Vet Pathol"},{"key":"2025050201523188500_CIT0054","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1503\/cmaj.080486","article-title":"Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis","volume":"180","author":"Loke","year":"2009","journal-title":"Can Med Assoc"},{"key":"2025050201523188500_CIT0055","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1210\/jc.2015-3167","article-title":"Effects of canagliflozin on fracture risk in patients with type 2 diabetes mellitus","volume":"101","author":"Watts","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2025050201523188500_CIT0056","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1007\/s00198-017-4051-y","article-title":"Use of dipeptidyl peptidase-4 inhibitors and risk of bone fracture in patients with type 2 diabetes in Germany-A retrospective analysis of real-world data","volume":"28","author":"Dombrowski","year":"2017","journal-title":"Osteoporos Int"},{"key":"2025050201523188500_CIT0057","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.1210\/jc.2015-2233","article-title":"Plasma DPP4 activities are associated with osteoporosis in postmenopausal women with normal glucose tolerance","volume":"100","author":"Zheng","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2025050201523188500_CIT0058","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/J.BONE.2016.08.009","article-title":"Boning up on DPP4, DPP4 substrates, and DPP4-adipokine interactions: logical reasoning and known facts about bone related effects of DPP4 inhibitors","volume":"92","author":"Glorie","year":"2016","journal-title":"Bone"},{"key":"2025050201523188500_CIT0059","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-3569-7_1","volume-title":"In Silico Identification and Characterization of Protein-Ligand Binding Sites","author":"Roche","year":"2016"},{"key":"2025050201523188500_CIT0060","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/FPUBH.2021.759236","article-title":"Combined effects of proton radiation and simulated microgravity on the cell viability and ALP activity of murine osteoblast cells","volume":"9","author":"Ma","year":"2021","journal-title":"Front Public Heal"},{"key":"2025050201523188500_CIT0061","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.3390\/ma14164414","article-title":"Osteoblast-like cell proliferation, ALP activity and photocatalytic activity on sintered anatase and rutile titanium dioxide","volume":"14","author":"Yokoi","year":"2021","journal-title":"Mater (Basel, Switzerland)"},{"key":"2025050201523188500_CIT0062","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/J.BONE.2015.05.025","article-title":"Dijke, Bone morphogenetic protein signaling in bone homeostasis","volume":"80","author":"S\u00e1nchez-Duffhues","year":"2015","journal-title":"Bone"},{"key":"2025050201523188500_CIT0063","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.1073\/pnas.87.12.4605","article-title":"Progressive changes in the protein composition of the nuclear matrix during rat osteoblast differentiation","volume":"87","author":"Dworetzky","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"2025050201523188500_CIT0064","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jep.2016.03.023","article-title":"Coordinate regulatory osteogenesis effects of icariin, timosaponin B II and ferulic acid from traditional Chinese medicine formulas on UMR-106 osteoblastic cells and osteoblasts in neonatal rat calvaria cultures","volume":"185","author":"Li","year":"2016","journal-title":"J Ethnopharmacol"},{"key":"2025050201523188500_CIT0065","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/2909454","article-title":"Overexpression of PIK3R1 promotes bone formation by regulating osteoblast differentiation and osteoclast formation","volume":"2021","author":"Zhu","year":"2021","journal-title":"Comput Math Methods Med"},{"key":"2025050201523188500_CIT0066","doi-asserted-by":"publisher","first-page":"607","DOI":"10.2217\/nnm-2021-0401","article-title":"Selenium nanoparticles stimulate osteoblast differentiation via BMP-2\/MAPKs\/\u03b2-catenin pathway in diabetic osteoporosis","volume":"17","author":"Poleboina","year":"2022","journal-title":"Nanomedicine (London, England)"},{"key":"2025050201523188500_CIT0067","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1006\/excr.2002.5483","article-title":"Overexpression of BMP-2 modulates morphology, growth, and gene expression in osteoblastic cells","volume":"274","author":"Huang","year":"2002","journal-title":"Exp Cell Res"},{"key":"2025050201523188500_CIT0068","doi-asserted-by":"publisher","first-page":"109796","DOI":"10.1016\/j.biopha.2019.109796","article-title":"Anagliptin stimulates osteoblastic cell differentiation and mineralization","volume":"129","author":"Dong","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"2025050201523188500_CIT0069","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1152\/physiol.00057.2014","article-title":"The VCD mouse model of menopause and perimenopause for the study of sex differences in cardiovascular disease and the metabolic syndrome","volume":"31","author":"Brooks","year":"2016","journal-title":"Physiology (Bethesda)"},{"key":"2025050201523188500_CIT0070","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00223-011-9565-2","article-title":"Decreased bone mineral density in rats rendered follicle-deplete by an ovotoxic chemical correlates with changes in follicle-stimulating hormone and inhibin A","volume":"90","author":"Lukefahr","year":"2012","journal-title":"Calcif Tissue Int"},{"key":"2025050201523188500_CIT0071","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.3390\/jcm10204775","article-title":"Effect of dipeptidyl peptidase-4 inhibitors on bone health in patients with type 2 diabetes mellitus","volume":"10","author":"Lee","year":"2021","journal-title":"J Clin Med"},{"key":"2025050201523188500_CIT0072","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/0004563213515190","article-title":"Biochemical markers of bone turnover:uses and limtations","volume":"51","author":"Hlaing","year":"2014","journal-title":"Ann Clin Biochem"},{"key":"2025050201523188500_CIT0073","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1002\/jbmr.4409","article-title":"Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the active-controlled fracture study in postmenopausal women with osteoporosis at high risk (ARCH) trial","volume":"36","author":"Brown","year":"2021","journal-title":"J Bone Miner Res"},{"key":"2025050201523188500_CIT0074","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1080\/00365510802233442","article-title":"Reduced bone mass and increased bone turnover in postmenopausal women with epilepsy using antiepileptic drug monotherapy","volume":"68","author":"Lyngstad-Brechan","year":"2008","journal-title":"Scand J Clin Lab Invest"},{"key":"2025050201523188500_CIT0075","doi-asserted-by":"publisher","first-page":"E447","DOI":"10.1152\/ajpendo.00217.2014","article-title":"DPP IV inhibitor treatment attenuates bone loss and improves mechanical bone strength in male diabetic rats","volume":"307","author":"Glorie","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2025050201523188500_CIT0076","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1016\/J.BMCL.2009.05.118","article-title":"Li, Synthesis and evaluation of 1-(benzo[b]thiophen-2-yl)ethanone analogues as novel anti-osteoporosis agents acting on BMP-2 promotor","volume":"19","author":"ying Liu","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"2025050201523188500_CIT0077","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/FENDO.2022.944323","article-title":"Linagliptin in combination with metformin ameliorates diabetic osteoporosis through modulating BMP-2 and sclerostin in the high-fat diet fed C57BL\/6 mice","volume":"13","author":"Nirwan","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025050201523188500_CIT0078","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/FPHAR.2017.00407","article-title":"Sitagliptin, an anti-diabetic drug, suppresses estrogen deficiency-induced osteoporosis in vivo and inhibits RANKL-induced osteoclast formation and bone resorption in vitro","volume":"8","author":"Wang","year":"2017","journal-title":"Front Pharmacol"},{"key":"2025050201523188500_CIT0079","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bcp.2016.04.010","article-title":"Pharmacological inhibition of cathepsin K: a promising novel approach for postmenopausal osteoporosis therapy","volume":"117","author":"Mukherjee","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"2025050201523188500_CIT0080","doi-asserted-by":"publisher","first-page":"e0168569","DOI":"10.1371\/journal.pone.0168569","article-title":"Protective effects of vildagliptin against pioglitazone-induced bone loss in type 2 diabetic rats","volume":"11","author":"Eom","year":"2016","journal-title":"PLoS One"},{"key":"2025050201523188500_CIT0081","doi-asserted-by":"publisher","first-page":"218","DOI":"10.5582\/ddt.2020.03073","article-title":"Effects of the linagliptin, dipeptidyl peptidase-4 inhibitor, on bone fragility induced by type 2 diabetes mellitus in obese mice","volume":"14","author":"Kanda","year":"2020","journal-title":"Drug Discov Ther"},{"key":"2025050201523188500_CIT0082","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1210\/en.2010-1098","article-title":"Differential effects of PPAR-{gamma} activation versus chemical or genetic reduction of DPP-4 activity on bone quality in mice","volume":"152","author":"Kyle","year":"2011","journal-title":"Endocrinology"},{"key":"2025050201523188500_CIT0083","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00223-018-0507-0","article-title":"Sitagliptin alters bone composition in high-fat-fed mice","volume":"104","author":"Mansur","year":"2019","journal-title":"Calcif Tissue Int"},{"key":"2025050201523188500_CIT0084","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1080\/1061186X.2023.2216894","article-title":"The combination of linagliptin and metformin rescues bone loss in type 2 diabetic osteoporosis","volume":"31","author":"Liu","year":"2023","journal-title":"J Drug Target"},{"key":"2025050201523188500_CIT0085","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7759\/cureus.32204","article-title":"Effects of linagliptin and pioglitazone on fracture healing in an experimental type 2 diabetes rat model","volume":"14","author":"Mraja","year":"2022","journal-title":"Cureus"},{"key":"2025050201523188500_CIT0086","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41467-019-14003-6","article-title":"Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolism","volume":"11","author":"Weivoda","year":"2020","journal-title":"Nat Commun"},{"key":"2025050201523188500_CIT0087","doi-asserted-by":"publisher","first-page":"6578","DOI":"10.3390\/ijms22126578","article-title":"Effects of incretin-related diabetes drugs on bone formation and bone resorption","volume":"22","author":"Kitaura","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025050201523188500_CIT0088","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3877\/cma.j.issn.2096-112X.2020.01.009","article-title":"Hyaluronic acid-based hydrogels with tobacco mosaic virus containing cell adhesive peptide induce bone repair in normal and osteoporotic rats","volume":"1","author":"Yuan","year":"2020","journal-title":"Biomater. Transl"},{"key":"2025050201523188500_CIT0089","doi-asserted-by":"publisher","first-page":"100881","DOI":"10.1016\/j.xcrm.2022.100881","article-title":"Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases","volume":"4","author":"Guo","year":"2023","journal-title":"Cell Rep Med"},{"key":"2025050201523188500_CIT0090","first-page":"185","article-title":"Abalone shell-derived Mg-doped mesoporous hydroxyapatite microsphere drug delivery system loaded with icariin for inducing apoptosis of osteosarcoma cells","volume":"5","author":"Liu","year":"2024","journal-title":"Biomater Transl"},{"key":"2025050201523188500_CIT0091","doi-asserted-by":"publisher","first-page":"102074","DOI":"10.1016\/j.nantod.2023.102074","article-title":"Delivery of m7G methylated Runx2 mRNA by bone-targeted lipid nanoparticle promotes osteoblastic bone formation in senile osteoporosis","volume":"54","author":"Liu","year":"2024","journal-title":"Nano Today"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/77\/5\/668\/59831730\/rgae112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/77\/5\/668\/59831730\/rgae112.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T05:53:01Z","timestamp":1746165181000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/77\/5\/668\/7808865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,3]]},"references-count":91,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,10,3]]},"published-print":{"date-parts":[[2025,5,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jpp\/rgae112","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2024,10,3]]}}}